Anne Wassermann

Anne Wassermann is an accomplished professional in the field of informatics and molecular research. With a diverse background in leading pharmaceutical companies like Bayer AG, Merck, and Pfizer, Anne has showcased her expertise in various scientific roles. She started her career as a Research Assistant at the University of Bonn and transitioned into roles of increasing responsibility.

As a Senior Scientist at Bayer AG, Anne contributes to the cutting-edge research and development initiatives within the organization. Her past experiences at Merck, Pfizer, and Novartis Institutes for BioMedical Research have equipped her with a deep understanding of molecular informatics and its applications in the pharmaceutical industry. Anne's journey from a Research Assistant to holding prestigious roles like Principal Scientist Informatics at Merck reflects her dedication and passion for scientific advancements.

Throughout her career, Anne Wassermann has been at the forefront of innovative research projects, driving solutions that have a tangible impact on the healthcare sector. Her contributions as an Associate Principal Scientist and Senior Scientist Molecular Informatics have been instrumental in shaping the informatics landscape in leading pharmaceutical companies. Anne's rich experience encompasses working in varied organizations, allowing her to bring a unique perspective to each role she undertakes.

Anne Wassermann's background as a Presidential Postdoctoral Fellow at Novartis Institutes for BioMedical Research underscores her commitment to academic and industry collaboration, bridging the gap between research and practical applications. Her journey in the scientific realm showcases a seamless transition from academia to corporate environments, where she has excelled in generating valuable insights and driving scientific innovations.

Overall, Anne Wassermann's professional journey is a testament to her expertise in informatics, molecular research, and pharmaceuticals. Her experience at renowned organizations like Bayer AG, Merck, Pfizer, and Novartis Institutes for BioMedical Research solidifies her position as a seasoned professional in the scientific community.